-
In the Moment- Summer 2016
Fran Keilt, Virginia White, Barbara Rascati.
-
Survivor Profile
In Support and ServiceRetired Army colonel and prostate cancer survivor Jim Williams asks men to pay better attention to their health.
by Lauren Gravitz
-
Treatment Is Waiting
For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
-
Yesterday & Today
A Kind and Decent ManWhether playing Franklin D. Roosevelt or Richard Gilmore, the wealthy scion in 'Gilmore Girls,' Edward Herrmann took on gentlemanly roles that mirrored his real-life persona. He died of brain cancer in 2014.
by Marilyn Fenichel
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
The Power of 1
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
-
The High-Deductible Gamble
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
-
In the Moment- Spring 2016
Colleen Bokor, Dana Stewart, Brittany Avin.
-
Yesterday & Today
A Storied LifeLiterary realist John Updike used the scaffold of his own life, including his lung cancer diagnosis, to explore the shared experiences of our time.
by Sue Rochman
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon